173 related articles for article (PubMed ID: 22925000)
1. STRoke Adverse outcome is associated WIth NoSocomial Infections (STRAWINSKI): procalcitonin ultrasensitive-guided antibacterial therapy in severe ischaemic stroke patients - rationale and protocol for a randomized controlled trial.
Ulm L; Ohlraun S; Harms H; Hoffmann S; Klehmet J; Ebmeyer S; Hartmann O; Meisel C; Anker SD; Meisel A
Int J Stroke; 2013 Oct; 8(7):598-603. PubMed ID: 22925000
[TBL] [Abstract][Full Text] [Related]
2. Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial.
Schuetz P; Christ-Crain M; Wolbers M; Schild U; Thomann R; Falconnier C; Widmer I; Neidert S; Blum CA; Schönenberger R; Henzen C; Bregenzer T; Hoess C; Krause M; Bucher HC; Zimmerli W; Müller B;
BMC Health Serv Res; 2007 Jul; 7():102. PubMed ID: 17615073
[TBL] [Abstract][Full Text] [Related]
3. The Randomized Controlled STRAWINSKI Trial: Procalcitonin-Guided Antibiotic Therapy after Stroke.
Ulm L; Hoffmann S; Nabavi D; Hermans M; Mackert BM; Hamilton F; Schmehl I; Jungehuelsing GJ; Montaner J; Bustamante A; Katan M; Hartmann A; Ebmeyer S; Dinter C; Wiemer JC; Hertel S; Meisel C; Anker SD; Meisel A
Front Neurol; 2017; 8():153. PubMed ID: 28484421
[TBL] [Abstract][Full Text] [Related]
4. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.
Christ-Crain M; Jaccard-Stolz D; Bingisser R; Gencay MM; Huber PR; Tamm M; Müller B
Lancet; 2004 Feb; 363(9409):600-7. PubMed ID: 14987884
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.
de Jong E; van Oers JA; Beishuizen A; Vos P; Vermeijden WJ; Haas LE; Loef BG; Dormans T; van Melsen GC; Kluiters YC; Kemperman H; van den Elsen MJ; Schouten JA; Streefkerk JO; Krabbe HG; Kieft H; Kluge GH; van Dam VC; van Pelt J; Bormans L; Otten MB; Reidinga AC; Endeman H; Twisk JW; van de Garde EMW; de Smet AMGA; Kesecioglu J; Girbes AR; Nijsten MW; de Lange DW
Lancet Infect Dis; 2016 Jul; 16(7):819-827. PubMed ID: 26947523
[TBL] [Abstract][Full Text] [Related]
6. Excluding infection through procalcitonin testing improves outcomes of congestive heart failure patients presenting with acute respiratory symptoms: results from the randomized ProHOSP trial.
Schuetz P; Kutz A; Grolimund E; Haubitz S; Demann D; Vögeli A; Hitz F; Christ-Crain M; Thomann R; Falconnier C; Hoess C; Henzen C; Marlowe RJ; Zimmerli W; Mueller B;
Int J Cardiol; 2014 Aug; 175(3):464-72. PubMed ID: 25005339
[TBL] [Abstract][Full Text] [Related]
7. Procalcitonin-guided antibiotic therapy in aspiration pneumonia and an assessment of the continuation of oral intake.
Ogasawara T; Umezawa H; Naito Y; Takeuchi T; Kato S; Yano T; Kasamatsu N; Hashizume I
Respir Investig; 2014 Mar; 52(2):107-13. PubMed ID: 24636266
[TBL] [Abstract][Full Text] [Related]
8. Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care.
Briel M; Schuetz P; Mueller B; Young J; Schild U; Nusbaumer C; Périat P; Bucher HC; Christ-Crain M
Arch Intern Med; 2008 Oct; 168(18):2000-7; discussion 2007-8. PubMed ID: 18852401
[TBL] [Abstract][Full Text] [Related]
9. Procalcitonin usefulness for the initiation of antibiotic treatment in intensive care unit patients.
Layios N; Lambermont B; Canivet JL; Morimont P; Preiser JC; Garweg C; Ledoux D; Frippiat F; Piret S; Giot JB; Wiesen P; Meuris C; Massion P; Leonard P; Nys M; Lancellotti P; Chapelle JP; Damas P
Crit Care Med; 2012 Aug; 40(8):2304-9. PubMed ID: 22809906
[TBL] [Abstract][Full Text] [Related]
10. Procalcitonin, a valuable biomarker assisting clinical decision-making in the management of community-acquired pneumonia.
Lindstrom ST; Wong EK
Intern Med J; 2014 Apr; 44(4):390-7. PubMed ID: 24528892
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy.
Stolz D; Christ-Crain M; Bingisser R; Leuppi J; Miedinger D; Müller C; Huber P; Müller B; Tamm M
Chest; 2007 Jan; 131(1):9-19. PubMed ID: 17218551
[TBL] [Abstract][Full Text] [Related]
12. Stop Antibiotics on guidance of Procalcitonin Study (SAPS): a randomised prospective multicenter investigator-initiated trial to analyse whether daily measurements of procalcitonin versus a standard-of-care approach can safely shorten antibiotic duration in intensive care unit patients--calculated sample size: 1816 patients.
Assink-de Jong E; de Lange DW; van Oers JA; Nijsten MW; Twisk JW; Beishuizen A
BMC Infect Dis; 2013 Apr; 13():178. PubMed ID: 23590389
[TBL] [Abstract][Full Text] [Related]
13. Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial.
Jensen JU; Hein L; Lundgren B; Bestle MH; Mohr TT; Andersen MH; Thornberg KJ; Løken J; Steensen M; Fox Z; Tousi H; Søe-Jensen P; Lauritsen AØ; Strange D; Petersen PL; Reiter N; Hestad S; Thormar K; Fjeldborg P; Larsen KM; Drenck NE; Ostergaard C; Kjær J; Grarup J; Lundgren JD;
Crit Care Med; 2011 Sep; 39(9):2048-58. PubMed ID: 21572328
[TBL] [Abstract][Full Text] [Related]
14. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial.
Christ-Crain M; Stolz D; Bingisser R; Müller C; Miedinger D; Huber PR; Zimmerli W; Harbarth S; Tamm M; Müller B
Am J Respir Crit Care Med; 2006 Jul; 174(1):84-93. PubMed ID: 16603606
[TBL] [Abstract][Full Text] [Related]
15. Procalcitonin guidance for reduction of antibiotic use in low-risk outpatients with community-acquired pneumonia.
Long W; Deng X; Zhang Y; Lu G; Xie J; Tang J
Respirology; 2011 Jul; 16(5):819-24. PubMed ID: 21507143
[TBL] [Abstract][Full Text] [Related]
16. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial.
Bouadma L; Luyt CE; Tubach F; Cracco C; Alvarez A; Schwebel C; Schortgen F; Lasocki S; Veber B; Dehoux M; Bernard M; Pasquet B; Régnier B; Brun-Buisson C; Chastre J; Wolff M;
Lancet; 2010 Feb; 375(9713):463-74. PubMed ID: 20097417
[TBL] [Abstract][Full Text] [Related]
17. Procalcitonin-based therapeutic strategy to reduce antibiotic use in patients after cardiac surgery: a randomized controlled trial.
Maravić-Stojković V; Lausević-Vuk L; Jović M; Ranković A; Borzanović M; Marinković J
Srp Arh Celok Lek; 2011; 139(11-12):736-42. PubMed ID: 22338468
[TBL] [Abstract][Full Text] [Related]
18. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial.
Schuetz P; Christ-Crain M; Thomann R; Falconnier C; Wolbers M; Widmer I; Neidert S; Fricker T; Blum C; Schild U; Regez K; Schoenenberger R; Henzen C; Bregenzer T; Hoess C; Krause M; Bucher HC; Zimmerli W; Mueller B;
JAMA; 2009 Sep; 302(10):1059-66. PubMed ID: 19738090
[TBL] [Abstract][Full Text] [Related]
19. Procalcitonin measurements for guiding antibiotic treatment in pediatric pneumonia.
Esposito S; Tagliabue C; Picciolli I; Semino M; Sabatini C; Consolo S; Bosis S; Pinzani R; Principi N
Respir Med; 2011 Dec; 105(12):1939-45. PubMed ID: 21959024
[TBL] [Abstract][Full Text] [Related]
20. Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study.
Stolz D; Smyrnios N; Eggimann P; Pargger H; Thakkar N; Siegemund M; Marsch S; Azzola A; Rakic J; Mueller B; Tamm M
Eur Respir J; 2009 Dec; 34(6):1364-75. PubMed ID: 19797133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]